DIA Health Technology Assessment (HTA) Forum

Creating a successful European HTA system to accelerate patient's access

Back to Agenda

Session 3: Framing The PICO – Working to a Common Understanding of a PICO

Session Chair(s)

Lara Wolfson

AVP & Head, HTA Statistics

MSD Switzerland, Switzerland

Tanja Podkonjak

Director, Oncology Access Policy EUCAN

Takeda Pharmaceuticals International AG, Switzerland

This session will showcase two recent PICO studies, aligning values, differences and solutions. elaborating on room for variability, treatment options and biomarkers. The workshop will address room for variability, treatment options, biomarkers, population vs subgroup with a goal of defining what constitutes an addressable PICO.

Have an account?

Download registration form Register